ROYAL BANK OF CANADA - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 40 filers reported holding THE ONCOLOGY INSTITUTE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$11,000
+175.0%
7,870
+1.4%
0.00%
Q2 2023$4,000
+300.0%
7,762
+286.4%
0.00%
Q1 2023$1,000
-90.0%
2,009
-66.4%
0.00%
Q4 2022$10,000
+233.3%
5,978
+893.0%
0.00%
Q3 2022$3,000
+200.0%
602
+467.9%
0.00%
Q2 2022$1,000
-75.0%
106
-81.7%
0.00%
Q1 2022$4,0005790.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q1 2023
NameSharesValueWeighting ↓
Parian Global Management LP 444,244$3,167,0006.52%
Velan Capital Investment Management LP 600,000$4,278,0003.97%
Triatomic Management LP 428,100$3,052,0002.48%
Empery Asset Management, LP 70,733$504,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,296,107$32,137,0000.72%
Redmile Group, LLC 2,414,432$17,215,0000.54%
Alpine Global Management, LLC 81,902$584,0000.07%
Saba Capital Management, L.P. 400,000$2,852,0000.04%
ExodusPoint Capital Management, LP 106,505$759,0000.01%
FMR LLC 12,000,000$85,560,0000.01%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders